YK-2-69

CAS No. 2619846-89-6

YK-2-69( —— )

Catalog No. M36287 CAS No. 2619846-89-6

YK-2-69 is a highly selective DYRK2 inhibitor with anti-prostate cancer effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 686 In Stock
10MG 938 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    YK-2-69
  • Note
    Research use only, not for human use.
  • Brief Description
    YK-2-69 is a highly selective DYRK2 inhibitor with anti-prostate cancer effects.
  • Description
    YK-2-69 is a highly selective DYRK2 inhibitor with anti-prostate cancer effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    DYRK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2619846-89-6
  • Formula Weight
    506.6
  • Molecular Formula
    C25H27FN8OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(C1=CN=C(C=C1)NC=2N=CC(F)=C(N2)C=3C=CC=4N=C(SC4C3)N(C)C)N5CCN(CC)CC5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Sarafotoxin B|SARAFO...

    Sarafotoxin S6b is a vasoconstrictor peptide, and a non-selective endothelin receptor agonist. Sarafotoxin S6b can induce contraction in isolated human coronary arteries , the Ki values of Coronary artery, Saphenous vein and Coronary artery are 0.27, 0.55 and 19.5 nM, respectively.

  • 2-Methoxyethanol

    2-Methoxyethanol is used in the synthesis of 2-aminothiazoles in the treatment of prion disease. 2-Methoxyethanol is also used in the preparation of Rho-associated kinase inhibitors or (ROCK) inhibitors for the treatment of cardiovascular disease.

  • MSH Release Inhibiti...

    MIF-1 (Melanostatin), an endogenous brain peptide, is a potent dopamine receptor allosteric modulator. MIF-1 inhibits melanin formation. MIF-1 blocks the effects of opioid receptor activation to modulate the analgesic effects. MIF-1 accesses from the blood to the CNS by directly crossing the blood-brain barrier (BBB).